USPTO serial 90898772
DAIM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 22, 2022
- Examiner
- CHUNG, ABBIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DAIM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph L. Morales
Joseph L. Morales THE MORALES LAW FIRM6628 WALNUTWOOD CIR.BALTIMORE, MD 21212UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vaccines; Chemical preparations for the diagnosis of diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for regulating the immune system; all of the aforesaid goods being for the diagnosis, treatment, management or prevention of Type 1 diabetes | ACTIVE | — |
| 010 | Medical test kits for diabetes monitoring for home use; Testing instruments for medical diagnostic purposes, namely, monitoring glucose level; Blood glucose testing apparatus; Apparatus for carrying-out diagnostic tests for medical purposes, namely, for diabetes testing; Diagnostic, examination, and monitoring equipment, namely, blood glucose monitor; Medical apparatus for testing the level of glucose in the blood; Medical apparatus and instruments for monitoring glucose levels; Medical diagnostic instruments for measuring glucose levels in blood; Medical testing instruments for recording blood glucose levels; all of the aforesaid goods being for use in the diagnosis, treatment, management or prevention of Type 1 diabetes | ACTIVE | — |
| 035 | Advertising services relating to pharmaceuticals for the treatment of diabetes; Advertising services relating to pharmaceuticals; Advertising, marketing and promotional services; Advertising; Advertising services to promote public awareness of medical conditions; Advertising services related to immune disorders; Advertising services related to autoimmune diseases; all of the aforesaid services being provided in connection with the diagnosis, treatment, management or prevention of Type 1 diabetes | ACTIVE | — |
| 044 | Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical screening; Health screening services in the field of diabetes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services for the diagnosis of conditions of the human body; Medical services; Medical diagnostic testing services; Medical services for the treatment of conditions of the human body; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical information services provided via the Internet; Providing medical information; Medical analysis services for autoimmune disease diagnosis and prognosis; all of the aforesaid services relating to the diagnosis, treatment, management or prevention of Type 1 diabetes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Daim Pharma Ltd
- Other trademarks owned by Daim Pharma Ltd
- Other trademarks owned by Daim Pharma Ltd
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named DAIM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 22, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 22, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 6, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 6, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 17, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 1, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 1, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 1, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 1, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 1, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 20, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jun 30, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2021 | NWAP | NEW APPLICATION ENTERED | — |